PMS [post marketing surveillance] assessing the safety and efficacy of telmisartan in patients with mild to moderate essential hypertension.
Phase of Trial: Phase IV
Latest Information Update: 18 May 2012
At a glance
- Drugs Hydrochlorothiazide; Telmisartan
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 18 May 2012 Actual patient number chnaged from (34329) to (33247) as reported by ClinicalTrials.gov.
- 05 Mar 2010 Actual patient number (34329) added as reported by ClinicalTrials.gov.
- 05 Mar 2010 Status change from recruiting to completed as reported by CliniclaTrials.gov record.